Key result
ECG-derived respiratory rate shows promise as a non-invasive biomarker to guide ICD therapy allocation.
Why the study?
Despite being an established marker of disease severity and mortality risk in cardiovascular disease, respiratory monitoring remains underused in routine clinical practice and remote telemonitoring.
Does electrocardiogram-derived respiration improve risk stratification and guide clinical decision-making in cardiac patients?
Does electrocardiogram-derived respiration improve risk stratification and guide clinical decision-making in cardiac patients?
Electrocardiogram-derived respiratory rate is a promising non-invasive biomarker for individualized risk stratification in cardiac patients, potentially guiding ICD therapy allocation.
Answers are grounded in this paper and cite their sources.
May expand respiratory monitoring in CV telemonitoring without added sensors; leaves open effects on risk prediction and outcomes.
Respiration is a fundamental vital sign and an established marker of disease severity and mortality risk, particularly in patients with cardiovascular disease. Despite its prognostic significance, respiratory monitoring remains underused in routine clinical practice and remote telemonitoring. At the same time, advances in biosignal processing enable robust extraction of respiratory information from the ubiquitous electrocardiogram, allowing respiratory assessment without additional sensors. This review highlights respiration as an underused biosignal in cardiovascular medicine and summarises physiological principles and technical approaches for electrocardiogram-derived respiration, including respiratory sinus arrhythmia, respiration-related QRS amplitude modulations, and electrical axis shifts. It emphasises the potential of electrocardiogram-derived respiration - especially nocturnal respiratory rate - in cardiac patients to enhance risk stratification and guide clinical decision-making, including patient selection for implantable cardioverter-defibrillator therapy. The feasibility of integrating nocturnal respiratory rate monitoring into standard surveillance of cardiac patients is discussed, alongside emerging evidence that this marker may identify patients with limited benefit from prophylactic implantable cardioverter-defibrillator therapy. The technical possibility to derive respiration from routine electrocardiographic recordings represents a significant yet underutilised opportunity. Electrocardiogram-derived respiratory rate is a promising scalable non-invasive biomarker for individualised risk stratification and may complement conventional indicators such as left-ventricular ejection fraction. Large-scale prospective randomised trials are now needed to establish whether incorporating electrocardiogram-derived respiratory markers into routine practice can improve patient outcomes and optimise therapy allocation.
No takes yet. Share an insight, caveat, or question.
Sanders et al. (2026) conducted a review in Cardiovascular disease. Electrocardiogram-derived respiration was evaluated. Electrocardiogram-derived respiratory rate is a promising non-invasive biomarker for individualised risk stratification in cardiac patients, potentially guiding ICD therapy allocation.
Synapse has enriched 10 related papers. Consider them for comparative context: